LRRK2 and Parkinson disease: GBA and LRRK2 mutations have been shown to affect lysosomal and mitochondrial phenotypes (12, –14), which contribute to the accumulation of PD-like neuropathology in mouse models, primary neurons, and human iPSC-derived cells (15, , –18).